Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Culture, Organoids & Tox Screening Europe 2019

Terry Riss's Biography



Terry Riss, Global Strategic Marketing Manager Cell Health, Promega Corporation

Dr. Riss received a PhD in Cell Biology from the University of Illinois in 1978 in the field of mammary gland biology. He did postdoctoral work at the University of Texas Medical School developing bioassays to study breast cancer. Dr. Riss moved to the Biotechnology division of Schering Plough in 1988 to develop interleukin/cytokine bioassays to support IND filings. Dr. Terry Riss started the Cell Biology program at Promega Corporation in 1990 where he has held several R&D and Project Management positions. Dr. Riss managed development of cell viability, cytotoxicity, apoptosis, and protease assay systems and lead efforts to promote multiplexing of cell-based assays to determine the mechanism of cell death. Dr. Riss now serves as Global Strategic Manager, Cell Health involved in outreach educational training activities. Dr. Riss serves as a co-editor of the NIH Assay Guidance Manual.

Terry Riss Image

Chairman's Welcome, Introduction to the Conference and Technology Landscape of 3D-Culture

Thursday, 13 June 2019 at 08:30

Add to Calendar ▼2019-06-13 08:30:002019-06-13 09:30:00Europe/LondonChairman's Welcome, Introduction to the Conference and Technology Landscape of 3D-Culture3D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com


Add to Calendar ▼2019-06-13 00:00:002019-06-14 00:00:00Europe/London3D-Culture, Organoids and Tox Screening Europe 20193D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com